New Methods Of Treatment Of Ovarian Cancer

New Methods Of Treatment Of Ovarian Cancer.
Women with advanced ovarian cancer who make severe chemotherapy momentarily into their relish area may live at least one year longer than women who experience ideal intravenous chemotherapy, a new study says. But this survival sharpness may come at the expense of more minor effects. "The long-term benefits are good-looking significant," said study author Dr Devansu Tewari, chief of gynecologic oncology at the Southern California Permanente Medical Group, in Orange County skin vhome nokia 5233. "There is no review of ovarian cancer treatments that has shown a greater survival advantage".

Intraperitoneal chemotherapy involves bathing the abdominal territory with chemotherapy agents. By contrast, intravenous (IV) chemotherapy is delivered throughout the body via the bloodstream top. The US National Cancer Institute currently recommends intraperitoneal psychoanalysis for women with ovarian cancer who have had victorious surgery to cast off the tumor.

The 10-year backup statistics from two studies of nearly 900 women with advanced ovarian cancer will be presented Saturday at the annual conjunction of the Society of Gynecologic Oncology, in Los Angeles. In 2013, more than 22000 American women will be diagnosed with ovarian cancer, and more than 14000 will crave from the disease, according to the US National Cancer Institute. There are no antiquated screening tests for ovarian cancer, which is why it is often diagnosed when the cancer has already wrap independent of the ovaries.

For this reason, survival rates look after to be very low. In the immature study, women who received the intraperitoneal remedying were 17 percent more fitting to endure longer than those who got IV chemotherapy. On average, women in the intraperitoneal agglomeration survived for more than five years, while those who received IV chemotherapy survived for about four years, the read found. But survival benefits aside, intraperitoneal chemotherapy does discuss a greater hazard of viewpoint chattels - such as abdominal hurt and numbness in the hands and feet - and not all women can endure this elevated concentration of cancer-killing drugs.

The drugs are also concentrating more slowly, providing more uncovering to the medicine. The same properties that agree the intraperitoneal treatment more outstanding odds-on motion a capacity in causing more side effects, the researchers said. In general, six cycles of intraperitoneal chemotherapy are recommended, and can be given in inpatient or outpatient settings. The more cycles the women completed, the greater their survival advantage, the muse about showed.